marijuana stocks news

OrganiGram Holdings Inc. (OGRMF)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Feb 28, 2015 Nov 30, 2014 Jul 31, 2014 Apr 30, 2014
Total Revenue 142   12   –   –  
Cost of Revenue 27 6
Gross Profit 115   6   –   –  
Operating Expenses
Research Development
Selling General and Administrative 539 723 177 24
Non Recurring 2
Others
Total Operating Expenses
Operating Income or Loss (423) (718) (177) (26)
Income from Continuing Operations
Total Other Income/Expenses Net 5
Earnings Before Interest And Taxes (423) (718) (172) (25)
Interest Expense 23
Income Before Tax (446) (718) (172) (25)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (446) (718) (172) (25)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (446) (718) (172) (25)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (446) (718) (172) (25)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$THCZ Announces Rocky Mountain High Has Been Restocked at AMAZON.com

Totally Hemp Crazy Inc. Announces Rocky Mountain High Has Been Restocked at…

 InMed Pharmaceuticals Inc. (IMLFF) Reports Second Quarter Fiscal 2019 Financial Results

InMed Pharmaceuticals Reports Second Quarter Fiscal 2019 Financial Results and Provides R&D…

$EAPH Announce Receipt of First Purchase Order For Mexico’s Launch

Easton Pharmaceuticals and Partner BMV Medica Announce Receipt of First Purchase Order…

GW Pharmaceuticals (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex® (cannabidiol oral solution) at the 2018 American Academy of Neurology Annual Meeting

LONDON, April 12, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (GWPH) “GW,”…